- Display 15 Products per page
Retail Clinics 2011: Growth of Stores, Best Venues, Winning Competitors, Supplier Sales of Products to Clinics, Clinic Sales Forecasts and Trends
Published: May 1, 2011 | Price: $150.00 – $300.00
Convenience clinics, also known as retail health clinics, are a quickly growing segment of the U.S. health care marketplace, although their expansion has slowed somewhat from the very high rates of their early years. This report looks at retail clinics’ impact and growth over the next five years. Although different operators employ slightly different approaches, the overall business model utilized by convenience clinics is quite consistent. It involves the provision of basic healthcare services at a low cost, in a...
2021 IVD Market Update and COVID-19 Impact
Published: March 12, 2021 | Price: $3,000.00 – $6,000.00
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
Abbott Diagnostics: Company Profile
Published: January 12, 2015 | Price: $500.00 – $1,000.00
Abbott Diagnostics: Company Profile Abbott Diagnostics: Company Profile opens with a discussion of top IVD suppliers, market trends, and general size and growth of the IVD market. Kalorama Information's report then focuses on a key company in the in vitro diagnostics (IVD) industry: Abbott Diagnostics. Abbott Laboratories is a global leader in the IVD industry, a global, diversified health care company active in pharmaceuticals, nutritionals, devices and diagnostics. Abbott's diagnostic products’ strength lies in their sheer presence worldwide. The company...
miRNA Research and Diagnostics Markets: Forecast to 2019
Published: September 4, 2014 | Price: $995.00 – $1,990.00
miRNA Research and Diagnostics Markets This report, miRNA Research and Diagnostic Markets, focuses on the test product potential of microRNA. These pieces of RNA are seen as important regulators of gene expression; including growth, form, differentiation, and apoptosis. They serve myriad functions as regulator molecules in post-transcriptional gene silencing. As the study details, a wide range of companies, both small biotechs and big pharmaceutical companies are committed to miRNA diagnostics. As part of its coverage of this topic, this report...
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)
Published: October 4, 2016 | Price: $2,396.00 – $4,792.00
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...
In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies
Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...
The U.S. Market for Over-The-Counter Pain Medication
Published: January 1, 2005 | Price: $3,000.00 – $6,000.00
The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key issues, drivers, challenges, regulations and trends affecting the marketplace. The report provides a comprehensive analysis of the pain medication products that are currently in the...
The World Liquid Biopsy Market
Published: May 30, 2019 | Price: $5,500.00 – $11,000.00
Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...
Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)
Published: January 25, 2016 | Price: $3,360.00 – $6,720.00
Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing) This Kalorama Information report, Hospital-Acquired Infections takes a solid look at Hospital-Acquired Infection Statistics Device Sterilization Market Hospital Area Disinfection Market HAI Testing Market Treatment Market Market Segmentation by Healthcare Location: Hospital, Nursing Home, Other Market Segmentation by Geographic Location: US, EU, Asia, Other Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking...
Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
Published: July 13, 2023 | Price: $3,750.00 – $7,500.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...
Cell and Gene Therapy Deals: Financings, Partnering, M&A, Technology Transfers, IPOs, and Other Developments
Published: February 16, 2022 | Price: $5,000.00 – $10,000.00
Cell and Gene Therapy Funding Reached $70 Billion in 2021. How Can You Keep Up with the Activity in this Industry? A lot of attention is being given to the areas related to cell and gene therapy (CGT) recently. There are now many approved therapies with proven track records. As the tools have lowered the barriers to entry for the industry, over a thousand companies have been created or become involved. Fortunately, Kalorama Information has been tracking every significant development in...
The 2019 Worldwide Market for Targeted Cancer Therapeutics
Published: April 16, 2019 | Price: $5,000.00 – $10,000.00
Kalorama Information has watched the cancer treatment market evolve over the past two decades and evaluated the impact new technologies are making on the market. The 2019 Worldwide Market for Targeted Cancer Therapeutics focuses on the expanding area of targeted therapies and includes current products available and discusses some of the most exciting developments in progress. This report covers targeted cancer therapies that do at least one of the following: Block or turn off chemical signals that tell the cancer...
Big Data and Healthcare
Published: August 26, 2014 | Price: $750.00 – $1,500.00
Big Data and Healthcare This Kalorama Information report, Big Data in Healthcare, outlines the key deals, mergers, consortia, and competitive events that have been formed in an attempt to meet the challenge of using healthcare data to enhance practice and boost revenues. Big data consists of the giant data pulls that emerge in every day use from manufacturers, healthcare organizations, governments, scientists and others. Those working with big data are seeking insights into the management of these large datasets. If...
The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025
Published: February 14, 2025 | Price: $5,600.00 – $8,000.00
Kalorama Information’s The World Market for HbA1c Testing: Trends, Technologies, and Growth Opportunities, 2025 provides a comprehensive analysis of the global HbA1c testing market, highlighting key trends, technological advancements, and growth opportunities. This report delves into the geographical distribution, demographic influences, and critical market issues shaping the industry. It offers a detailed examination of market values, regional dynamics, and competitive landscapes, with insights into leading providers. Since the 1990s, HbA1c testing has been pivotal in monitoring long-term glycemic control in...
Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline
Published: April 21, 2020 | Price: $4,000.00 – $8,000.00
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and...